BMS-813160
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for BMS-813160, covering 2011-02-11 to 2025-12-03. Get the full timeline:
Most recent: Clinical Trial Update: Trial of Neoadjuvant and Adjuvant Nivolumab and BMS-813160 With or Without GVAX for Locally Advanced Pancreatic Ductal Adenocarcinomas. [Phase 1, Phase 2]